Therefore, we determined if the increased susceptibility of metastatic cancer cells over-expressing c-Myc to TRAIL-induced apoptosis was accompanied by the increased activation of caspases (Figure 6A). The gene discussed is MYC; the disease is metastatic malignant neoplasm.